Previous Close | 67.76 |
1-Year Change | 0.43% |
6-Months Change | -23.98% |
3-Months Change | -0.73% |
Moving Avg (50d) | 67.444 |
Moving Avg (200d) | 80.042 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 41.1B |
Beta (3-Years) | 0.97 |
Revenue Growth (ttm) | 8.49% |
Net Profit Margin (ttm) | 24.66% |
Return On Assets (ttm) | 15.31% |
EPS (ttm) | 2.34 |
PE Ratio (ttm) | 28.96 |
Dividend Yield | % |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Health Care Technology |
Country: | United States |
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the SAPIEN transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter. The company has manufacturing facilities at the Irvine headquarters, as well as in... Wikipedia